January 16, 2022 - The NASH Podcast - Surfing the NASH Tsunami Podcast

S3-E4.4 – NASH-TAG 2022 Wrap-Up: Improving Cost Efficiency of NASH Trials By Reducing Screen Fail Rates

First-timers Amy Articolo (Novo Nordisk), Erin Quirk (Terns Pharmaceuticals) and Rachel Zayas (AGED Diagnostics) join the Surfers and guest KOL Ian Rowe to explore what NASH-TAG 2022 taught us about improving clinical trial efficiency by reducing screen fail rates.

January 16, 2022

S3-E4.3 – NASH-TAG 2022 Wrap-up: NITs from The FDA and Patients’ Perspectives

First-timers Amy Articolo (Novo Nordisk), Erin Quirk (Terns Pharmaceuticals) and Rachel Zayas (AGED Diagnostics) join the Surfers and guest KOL Ian Rowe to explore messages for patients and regulators from the firecis NASH-TAG 2022.

January 16, 2022

Day: January 16, 2022

All Podcast Categories

S3-E4.4 – NASH-TAG 2022 Wrap-Up: Improving Cost Efficiency of NASH Trials By Reducing Screen Fail Rates

S3-E4.3 – NASH-TAG 2022 Wrap-up: NITs from The FDA and Patients’ Perspectives

Discussion Group

Join The Discussion in our LinkedIn or Facebook Discussion Groups

Join The Live Recordings

Recording for this session will take place at 3:15p Eastern US time (1900H CET, 1800H BT) on Monday.

Join The Discussion…

Surfing The NASH Tsunami Podcast

S3-E26 – What Are We Learning About Clinical Trial Best Practices For NITs?

S3-E25.6 – Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management

S3-E25.5 – Emerging Concepts in NASH: Fatty Liver Pathophysiology, Epidemiology, Co-Morbidities

S3-E25.4 – NASH Drug Development in 2022: Will Quality of Life Data Help NASH Drugs Over the Finish Line?

S3-E25.3 – Future NASH Drug Development: More Diverse Trial Populations and More Study of Combination NASH Drugs

S3-E25.2 – NASH Drug Development In 2022: A Wealth of Data and a Promising NASH Pipeline

S3-E25.1 – NASH Drug Development in 2022: Late-Stage NASH Drugs and Their Path to Market

S3-E25 – Crystal Ball Looks at Drug Development and the NASH Pipeline

S3-E24.5 – From #INCBCN: Digital Health and Patient Empowerment: a Conversation with Dr. Marcus Ranney

S3-E24.4 – Innovations in NAFLD Care Conference: What Is the Importance of Steatosis in Metabolic Health?